Search

Your search keyword '"Walsh, Liron"' showing total 3 results
Start Over Author "Walsh, Liron" Language undetermined
3 results on '"Walsh, Liron"'

2. Additional file 3: of A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease

Author

Byrne, Barry, Tarekegn Geberhiwot, Barshop, Bruce, Barohn, Richard, Derralynn Hughes, Bratkovic, Drago, Desnuelle, Claude, Laforet, Pascal, Mengel, Eugen, Roberts, Mark, Haroldsen, Peter, Reilley, Kristin, Jayaram, Kala, Yang, Ke, and Walsh, Liron

Abstract

Change from baseline in maximum voluntary ventilation (MVV). Mean changes from baseline to week 72 in subjects receiving 20Â mg/kg reveglucosidase alfa infusion every 2Â weeks. Baseline is defined as the last measurement prior to the first infusion. The error bars represent the standard deviations. The statistical significance of treatment effects was not determined, as no pre-planned statistical analyses were conducted for this study. (PDF 122Â kb)

Published
2017
Full Text
View/download PDF

3. Additional file 2: of A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease

Author

Byrne, Barry, Tarekegn Geberhiwot, Barshop, Bruce, Barohn, Richard, Derralynn Hughes, Bratkovic, Drago, Desnuelle, Claude, Laforet, Pascal, Mengel, Eugen, Roberts, Mark, Haroldsen, Peter, Reilley, Kristin, Jayaram, Kala, Yang, Ke, and Walsh, Liron

Subjects
stomatognathic system, fungi, virus diseases, digestive system diseases
Abstract

Mean anti-BMN 701 (reveglucosidase alfa) antibody titers (safety population). (DOCX 16Â kb)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results